Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Margolis Institute for Health Policy at Duke University with offices at Duke and Washington DC. The new Institute supports and conducts research, evaluation, implementation, and educational activities to improve health policy and health, through collaboration across Duke University and Health System, and through partnerships between the public and private sectors.

Dr. McClellan is a doctor and an economist, and his work has addressed a wide range of strategies and policy reforms to improve health care. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy.

Dr. McClellan is a member of the National Academy of Medicine and chairs the Academy’s Leadership Council for Value and Science-Driven Health Care, co-chairs the guiding committee of the Health Care Payment Learning and Action Network, and is a research associate at the National Bureau of Economic Research. He has also previously served as a member of the President’s Council of Economic Advisers and Senior Director for Health Care Policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury. He was previously an Associate Professor of Economics and Medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.

Dr. McClellan, a founding board member, joined the Reagan-Udall Foundation for the FDA Board of Directors in 2008.